Phibro Animal Health (NASDAQ:PAHC) Hits New 1-Year High at $19.79

Shares of Phibro Animal Health Co. (NASDAQ:PAHC) reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $19.79 and last traded at $19.75, with a volume of 33713 shares changing hands. The stock had previously closed at $19.01.

Wall Street Analysts Forecast Growth

Separately, Barclays upped their price target on Phibro Animal Health from $10.00 to $13.00 and gave the stock an “underweight” rating in a research note on Friday, May 10th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $14.75.

Phibro Animal Health Trading Up 10.2 %

The firm’s 50 day moving average price is $17.89 and its 200-day moving average price is $15.70. The company has a debt-to-equity ratio of 1.69, a current ratio of 3.16 and a quick ratio of 1.67. The stock has a market cap of $848.13 million, a P/E ratio of 65.44, a P/E/G ratio of 4.71 and a beta of 0.57.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th will be given a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, September 4th. This represents a $0.48 annualized dividend and a yield of 2.29%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 150.00%.

Institutional Trading of Phibro Animal Health

A number of institutional investors and hedge funds have recently modified their holdings of the business. Illinois Municipal Retirement Fund boosted its position in shares of Phibro Animal Health by 7.2% during the first quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock valued at $148,000 after buying an additional 765 shares during the last quarter. CWM LLC grew its stake in shares of Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after acquiring an additional 1,035 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in shares of Phibro Animal Health by 7.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock valued at $200,000 after purchasing an additional 1,063 shares during the last quarter. China Universal Asset Management Co. Ltd. lifted its position in Phibro Animal Health by 65.0% during the first quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock valued at $50,000 after purchasing an additional 1,531 shares during the period. Finally, Cardinal Capital Management boosted its holdings in Phibro Animal Health by 4.7% in the second quarter. Cardinal Capital Management now owns 56,027 shares of the company’s stock worth $940,000 after purchasing an additional 2,520 shares during the last quarter. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.